Follow-up Mendelian randomization analyses provided weak evidence for a causal role of 2 of these proteins in type 2 diabetes-related cancer, specifically furin and glycoprotein Nmb in breast cancer risk. The gene discussed is FURIN; the disease is breast carcinoma.